Rivastigmine for the treatment of dementia associated with Parkinson’s disease

Overview of attention for article published in Neuropsychiatric Disease and Treatment, January 2008

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 85 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease

Article in Journal of Controlled Release (May 2023)

The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies

Article in Neurochemistry International (June 2022)

Real-life consequences of cognitive dysfunction in Parkinson's disease

Book chapter (February 2022)